ERAS

Erasca, Inc.

Healthcare · Biotechnology

$16.25

+$0.09+0.56%

Delayed · 2026-09-15T20:00:00.000Z · marketstack

all 3 open-market sales on file ran under a pre-arranged trading plan ($2.28M), so none was a decision taken that week. Who, and when

Aug 24, 2026$16.25

−$1.35−7.67%over 1M

Session

Day range95% of range

$15.54$16.29

Fundamentals

Visualize fundamentals and more

Market cap: 5.06B
P/E ratio: -

Risk factors, year on year

Item 1AMar 2026 10-KMar 2025

added: 45
dropped: 46
re-drafted: 44

Out of 275 passages in this year’s Item 1A.

New this year

• evolving government regulation that impacts the way we operate, including the potential negative effects of changes in United States tariff and import/export regulations; and

90 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Reimbursement
Product recalls
Cybersecurity
Tariffs
China
Litigation
Export controls

And 11 more.

FDA approval
This will require us to be successful in a range of challenging activities, including completing clinical trials and preclinical studies of our product candidates, discovering, acquiring or in-licensing additional product candidates, obtaining regulatory …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

23 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 15, 2026 · the last close

Erasca, Inc. investor relations

What ERAS has filed with the SEC. This is not Erasca, Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Erasca, Inc.

Also filed under Biotechnology, ranked by how closely they sit beside ERAS.

MRNAModerna, Inc.compare with ERAS
ROIVRoivant Sciences Ltd.compare with ERAS
VRTXVertex Pharmaceuticals Inc. / MA

What an account lets you do with Erasca, Inc.

Be told the moment a ERAS insider trades
Put Erasca, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Erasca, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Erasca, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2026.

FDA approval
Reimbursement
Product recalls
Cybersecurity
Tariffs
China
Litigation
Export controls

And 11 more.

FDA approval
This will require us to be successful in a range of challenging activities, including completing clinical trials and preclinical studies of our product candidates, discovering, acquiring or in-licensing additional product candidates, obtaining regulatory …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Session

Fundamentals

Risk factors, year on year

What it says it is exposed to

Recent activity

Discussion

Erasca, Inc. investor relations

Companies like Erasca, Inc.

Ask about Erasca, Inc.

What an account lets you do with Erasca, Inc.

Recent activity

What it says it is exposed to

Risk factors, year on year